PYK-2 is tyrosine phosphorylated after activation of pituitary adenylate cyclase activating polypeptide receptors in lung cancer cells. [electronic resource]
Producer: 20130419Description: 660-6 p. digitalISSN:- 1559-1166
- Calcium Signaling -- drug effects
- Cell Line, Tumor -- drug effects
- Chelating Agents -- pharmacology
- Cytosol -- drug effects
- Egtazic Acid -- analogs & derivatives
- Estrenes -- pharmacology
- Focal Adhesion Kinase 2 -- metabolism
- Humans
- Isoquinolines -- pharmacology
- Lung Neoplasms -- pathology
- Neoplasm Proteins -- metabolism
- Peptide Fragments -- pharmacology
- Phosphodiesterase Inhibitors -- pharmacology
- Phosphorylation -- drug effects
- Phosphotyrosine -- metabolism
- Pituitary Adenylate Cyclase-Activating Polypeptide -- antagonists & inhibitors
- Protein Kinase Inhibitors -- pharmacology
- Protein Processing, Post-Translational -- drug effects
- Pyrrolidinones -- pharmacology
- Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I -- drug effects
- Sulfonamides -- pharmacology
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Intramural
There are no comments on this title.
Log in to your account to post a comment.